02206nam 2200505 450 991016487740332120211025143502.01-60846-750-3(CKB)3710000001052078(MiAaPQ)EBC4800186(Au-PeEL)EBL4800186(CaPaEBR)ebr11338290(CaONFJC)MIL991780(OCoLC)972292236(EXLCZ)99371000000105207820170220h20172017 uy 0engurcnu||||||||rdacontentrdamediardacarrier<<">>When the Welfare People Come" race and class in the US child protection system /Don LashChicago, Illinois :Haymart Books,2017.©20171 online resource (234 pages)Includes index.1-60846-743-0 The "orphan trains" : then and now -- Moving toward a racialized child welfare system -- Parents with disabilities -- Foster youth -- Foster parents -- Juvenile "justice" -- Toiling inside the bureaucracy -- The future of child welfare -- Real reform -- Child welfare and social reproduction -- Socialism and the parent-child relationship -- Appendix : from rights to reality : a plan for parent advocacy and family-centered child welfare reform.In this groundbreaking look at the history and politics of the US child welfare system, 'When the Welfare People Come' exposes the system in its totality, from child protective investigation to foster care and mandated services, arguing that it constitutes a mechanism of control exerted over poor and working class parents and children.Child welfareUnited StatesFoster home careUnited StatesParent and childUnited StatesElectronic books.Child welfareFoster home careParent and child362.70973Lash Don1046705MiAaPQMiAaPQMiAaPQBOOK9910164877403321When the Welfare People Come"2473817UNINA01010nam a2200241Mi 4500991001029909707536110127s 000 0 ita d97888766737338876673733b1394938x-39ule_instDip.to Filologia Ling. e Lett.itaTesi, Riccardo 289467Un'immensa molteplicità di lingue e stili :studi sulla fine dell'italiano letterario della tradizione /Riccardo Tesi ; con gli indici a cura di Francesca FlorimbiiFirenze :F. Cesati,2009278 p. ;23 cm.Strumenti di linguistica italiana ;3Include bibliografia.b1394938x02-04-1427-01-11991001029909707536LE008 FL.M. (f.r.) XXII D 3612008000430979le008-E0.00-l- 00000.i1522346227-01-11Immensa molteplicità di lingue e stili250942UNISALENTOle00827-01-11ma -itait 3004080nam 22006375 450 991029844690332120251116151104.03-319-20273-110.1007/978-3-319-20273-0(CKB)3710000000484441(EBL)4178316(SSID)ssj0001583756(PQKBManifestationID)16263969(PQKBTitleCode)TC0001583756(PQKBWorkID)14866134(PQKB)11726419(DE-He213)978-3-319-20273-0(MiAaPQ)EBC4178316(PPN)190523832(EXLCZ)99371000000048444120150907d2015 u| 0engur|n|---|||||txtccrThe Adenosinergic System A Non-Dopaminergic Target in Parkinson’s Disease /edited by Micaela Morelli, Nicola Simola, Jadwiga Wardas1st ed. 2015.Cham :Springer International Publishing :Imprint: Springer,2015.1 online resource (344 p.)Current Topics in Neurotoxicity,2363-9563 ;10Description based upon print version of record.3-319-20272-3 Includes bibliographical references at the end of each chapters and index.Adenosine A2A receptors: localization and function -- Allosteric Mechanisms in the adenosine A2A-dopamine D2 receptor heteromer -- Adenosine A2A receptor antagonists in drug development -- Adenosine A2A Receptors and Neurotrophic Factors: Relevance for Parkinson's Disease -- Role of adenosine A2A receptors in the control of neuroinflammation – relevance for Parkinson’s disease -- Purines in Parkinson's: Adenosine A2A receptors and urate as targets for neuroprotection -- Adenosine A2A receptor antagonists as drugs for symptomatic control of Parkinson’s disease in preclinical studies -- Dopamine/adenosine interactions related to tremor in animal models of Parkinsonism -- Adenosine A2A receptor antagonists in L-DOPA-induced motor fluctuations -- Adenosine A2A receptor-mediated control of non-motor functions in Parkinson’s disease -- Imaging Studies with A2A Receptor Antagonists -- Caffeine and neuroprotection in Parkinson's disease -- The story of istradefylline – the first approved A2A antagonist for the treatment of Parkinson’s disease -- Adenosinergic Receptor Antagonists: Clinical Experience in Parkinson's Disease -- Adenosinergic regulation of sleep-wake behavior in the basal ganglia.Adenosine A2A receptor antagonists have shown great promise in the treatment of Parkinson's Disease and alleviation of symptoms. This book addresses various aspects of this class of drugs from their chemical development to their clinical use. Among the many insightful chapters contained in this book, there are three unique reviews that have not previously been published in any format: (1) a history of istradefylline, the first A2A antagonist approved for treatment of Parkinson's Disease, (2) an overview of neuroimaging studies in human health and disease, and (3) a study of urate as a possible biomarker and neuroprotectant.Current Topics in Neurotoxicity,2363-9563 ;10NeurosciencesNeurologyNeuroscienceshttps://scigraph.springernature.com/ontologies/product-market-codes/B18006Neurologyhttps://scigraph.springernature.com/ontologies/product-market-codes/H36001Neurosciences.Neurology.Neurosciences.Neurology.616.833Morelli Micaelaedthttp://id.loc.gov/vocabulary/relators/edtSimola Nicolaedthttp://id.loc.gov/vocabulary/relators/edtWardas Jadwigaedthttp://id.loc.gov/vocabulary/relators/edtMiAaPQMiAaPQMiAaPQBOOK9910298446903321The Adenosinergic System2533196UNINA